患有细胞癌的患者的转移切除术后辅助疗法:系统性审查
Steven Monda1, Primo N Lara1, Shuchi Gulati1
1University of California Davis Comprehensive Cancer Center, Sacramento, CA, USA.
Kidney cancer (Clifton, Va.)
|September 12, 2024
概括
布罗利祖马布在切除后对转移性清细胞脏细胞癌 (ccRCC) 患者的生存益处. 然而,其他辅助疗法在这个M1 NED群体中没有显示出类似的生存改善.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫治疗是一种免疫疗法.
背景情况:
- 辅助布罗利祖马布已被批准用于高风险的清细胞细胞癌 (ccRCC) 切割后.
- 切除转移性疾病 (M1 NED) 的患者可能从辅助 pembrolizumab.
- 了解M1 NED ccRCC中的全身性药物疗效至关重要,因为治疗方法正在进步.
研究的目的:
- 系统地审查细胞癌 (RCC) 中转移切除术后辅助疗法的试验.
主要方法:
- 按照PRISMA指南进行了系统的文献搜索,使用PubMed和Embase直到2024年1月.
- 包括的研究集中在完全切除的转移性RCC患者 (M1 NED),不包括只有局部晚期或N1疾病的患者.
- 识别的文章经过标题/摘要选,然后进行全文审查和描述性分析.
主要成果:
- 在最初的149个已识别的文章中,有9篇文章符合纳入标准.
- 分析侧重于M1 NED患者转移切除术后的辅助向治疗和免疫治疗.
- 只有潘布罗利祖马布 ( pembrolizumab) 证明了与改善生存率的关联;其他辅助疗法没有.
结论:
- 布罗利祖马布似乎为M1 NED ccRCC患者在切除后提供了显著的益处.
- 这种生存益处在M1 NED ccRCC群体中没有被其他辅助剂复制.
- 未来的研究应该确定特定的M1 NED患者亚组,这些患者可以从辅助治疗中受益.
更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.5K
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
相关概念视频
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K